United Therapeutics (UTHR) Tops Q1 EPS by 38c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq slides over 1% as Alphabet results revive AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $596.73 +1.75%
EPS Growth %: -13.3%
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
EACO, ITGR, CARE, More
EPS Growth %: -13.3%
Financial Fact:
Income from continuing operations before income taxes: 239.1M
Today's EPS Names:
EACO, ITGR, CARE, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $6.17, $0.38 better than the analyst estimate of $5.79. Revenue for the quarter came in at $677.7 million versus the consensus estimate of $620.31 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stagwell Inc (STGW) Tops Q3 EPS by 3c ; Offers Guidance
- Exlservice (EXLS) PT Raised to $48 at Stifel
- Perella Weinberg Partners (PWP) Tops Q3 EPS by 22c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
